9 September 2020
18 September 2020
Procurement of Automated Polymerase Chain Reaction Diagnostic Tests
15 September 2020
Antigen-Detection Diagnostic Test Procurement
The COVID-19 pandemic is having a catastrophic impact on the most vulnerable communities around the world and threatens progress against HIV, TB and malaria.
Under the World Health Organization’s leadership, the Global Fund is using its experience working with partners and governments in more than 100 countries to coordinate our response on a massive global scale.
We are providing guidance, tools and immediate funding of more than US$1 billion to help countries fight COVID-19, mitigate the impacts on lifesaving HIV, TB and malaria programs, and prevent fragile health systems from being overwhelmed. In this section we explain the operational details of our response, including funding application materials, technical guidance, situation reports, procurement instructions, and more.
A disease like COVID-19 threatens us all. We must unite to fight.
The Global Fund reacted decisively to the emergence of COVID-19, quickly making available more than US$1 billion to support countries through:
Our continuously updated report details approved COVID-19 response funding by country and multicountry program:
Through the COVID-19 Response Mechanism, countries can access funding to reinforce the response to COVID-19, mitigate the impact of the pandemic on HIV, TB and malaria programs, and make urgent improvements in health and community systems. US$665 million is currently allocated through the mechanism. Learn more
Through grant flexibilities, countries can use up to 5% of existing Global Fund grants to fight COVID-19 and mitigate the impact the pandemic has on HIV, TB and malaria programs. Up to US$500 million is available through these grant savings and reprogramming. Learn more
Our partnership urgently needs US$5 billion to continue to fight COVID-19, protect health workers and systems for health, and defend progress against HIV, TB and malaria in the countries where we invest. Learn more